Reaction
Enterovesical Fistula reporting signals
As of the last recalculation, Enterovesical Fistula appears in 745 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is MESALAMINE (PRR 19.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mesalamine | 38 | 19.9 | 19.9 |
| Isoniazid | 11 | 19.2 | 19.3 |
| Oxaliplatin | 38 | 15.0 | 15.0 |
| Fluorouracil Cream, 0.5% | 38 | 14.6 | 14.6 |
| Fluorouracil | 38 | 14.4 | 14.4 |
| Irinotecan Hydrochloride | 6 | 13.1 | 13.1 |
| Vedolizumab | 34 | 11.5 | 11.5 |
| Panitumumab | 6 | 10.8 | 10.8 |
| Cetuximab | 10 | 9.0 | 9.0 |
| Lenvatinib | 9 | 7.7 | 7.7 |
| Isotretinoin | 13 | 7.5 | 7.5 |
| Axitinib | 5 | 7.2 | 7.2 |